Patient 6 Brachioradialis with BoNTA EMG
Release Date: May 7, 2020
Last Reviewed: April 30, 2020
Expiration Date: May 7, 2021
Time to Complete Activity: 5-15 minutes
*This activity expired for credit on May 7, 2021, and is no longer available for credit
This activity is provided by Paradigm Medical Communications, LLC.
Target Audience
This activity has been designed to address the educational needs of neurologists and physiatrists. It may also be of benefit to other physicians, nurses, and healthcare providers who perform injection therapy for movement disorders.
Statement of Need
In the specialties of neurology and physiatry, injection of botulinum neurotoxin (BoNT) is now the treatment of choice for a wide range of movement disorders and other neurologic conditions that typically cause pain and discomfort, interfere with quality of life, and require long-term treatment. To provide their patients with the optimal outcomes, clinicians must be able to accurately localize muscle targets and inject appropriate BoNT doses. This activity is designed to provide expert instruction for clinicians to enhance their skills using BoNT injection therapy, with the ultimate goal of improving outcomes for patients.
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
- Apply best practices for accurate delivery of botulinum neurotoxins to the appropriate target muscles for treatment of movement disorders, including use of ultrasonography-guided techniques.
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 0.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Commercial Support
This activity is supported by an educational grant from Merz North America, Inc.
Instructions for Participation
To receive a CME certificate of participation, you should:
- Follow instructions to register or log in with your professional information
- View the online activity in its entirety
- Complete and submit the online posttest and evaluation
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
There is no fee required for participation in this activity.
Once you complete an activity, you will be able to re-watch the video at any time.
- To access the video again, click on “My Courses” at the top of your screen before closing the activity window, or visit www.paradigmmc.com/transcript at any time
- If you are not already logged in, you will need to enter your email address and password
- Click on the “Content” button to the right of the video you want to re-watch
This certified CME activity is designed using HTML5 video. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers:
For Desktops (Windows/Mac)
Microsoft Edge 40 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com.
Disclosures
In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Faculty
Katharine Alter, MD
Royalty: Demos Medical Publishing
Sherry Downie, PhD
Consulting Fees: Allergan, Inc.
Speakers Bureau: Allergan, Inc.
Nicholas Ketchum, MD
Consulting Fees: Medtronic; Merz North America, Inc.
Speakers Bureau: Allergan, Inc.; Ipsen Biopharmaceuticals, Inc.; Medtronic; Merz North America, Inc.
John McGuire, MD
Consulting Fees: Allergan, Inc.; Merz North America, Inc.; Saol Therapeutics
Speakers Bureau: Allergan, Inc.; Medtronic; Merz North America, Inc.
Michael Munin, MD
No financial relationships to disclose.
David Simpson, MD
Consulting Fees: Allergan, Inc.; Ipsen Biopharmaceuticals, Inc.; Merz North America, Inc.
Speakers Bureau: Allergan, Inc.; Ipsen Biopharmaceuticals, Inc.; Merz North America, Inc.
Grant/Research Support: Allergan, Inc.; Ipsen Biopharmaceuticals, Inc.; Merz North America, Inc.
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
Independent peer reviewer has no financial relationships to disclose.
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.
Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. In this activity, the trade names for neuromodulators are used for clarity. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.
Privacy policy
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website"). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
© 2020 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.